265 related articles for article (PubMed ID: 22589410)
1. FES kinase promotes mast cell recruitment to mammary tumors via the stem cell factor/KIT receptor signaling axis.
Kwok E; Everingham S; Zhang S; Greer PA; Allingham JS; Craig AW
Mol Cancer Res; 2012 Jul; 10(7):881-91. PubMed ID: 22589410
[TBL] [Abstract][Full Text] [Related]
2. Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors.
Smith JA; Samayawardhena LA; Craig AW
Cell Signal; 2010 Mar; 22(3):427-36. PubMed ID: 19892014
[TBL] [Abstract][Full Text] [Related]
3. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
Samayawardhena LA; Hu J; Stein PL; Craig AW
Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
[TBL] [Abstract][Full Text] [Related]
4. FES kinase participates in KIT-ligand induced chemotaxis.
Voisset E; Lopez S; Chaix A; Vita M; George C; Dubreuil P; De Sepulveda P
Biochem Biophys Res Commun; 2010 Feb; 393(1):174-8. PubMed ID: 20117079
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
6. FES/FER kinase signaling in hematopoietic cells and leukemias.
Craig AW
Front Biosci (Landmark Ed); 2012 Jan; 17(3):861-75. PubMed ID: 22201778
[TBL] [Abstract][Full Text] [Related]
7. Contributions of F-BAR and SH2 domains of Fes protein tyrosine kinase for coupling to the FcepsilonRI pathway in mast cells.
McPherson VA; Everingham S; Karisch R; Smith JA; Udell CM; Zheng J; Jia Z; Craig AW
Mol Cell Biol; 2009 Jan; 29(2):389-401. PubMed ID: 19001085
[TBL] [Abstract][Full Text] [Related]
8. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.
Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L
Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636
[TBL] [Abstract][Full Text] [Related]
9. Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells.
Shivakrupa R; Linnekin D
Cell Signal; 2005 Jan; 17(1):103-9. PubMed ID: 15451030
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles for the SgIGSF adhesion molecule and c-kit receptor tyrosine kinase in the interaction between mast cells and the mesentery.
Watabe K; Ito A; Koma Y; Wakayama T; Iseki S; Shinomura Y; Kitamura Y
Biochem Biophys Res Commun; 2004 Nov; 324(2):782-8. PubMed ID: 15474495
[TBL] [Abstract][Full Text] [Related]
11. The early growth response factor-1 contributes to interleukin-13 production by mast cells in response to stem cell factor stimulation.
Li B; Berman J; Wu P; Liu F; Tang JT; Lin TJ
J Immunotoxicol; 2008 Apr; 5(2):163-71. PubMed ID: 18569387
[TBL] [Abstract][Full Text] [Related]
12. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
[TBL] [Abstract][Full Text] [Related]
13. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.
Reber L; Da Silva CA; Frossard N
Eur J Pharmacol; 2006 Mar; 533(1-3):327-40. PubMed ID: 16483568
[TBL] [Abstract][Full Text] [Related]
14. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor.
Gattei V; Aldinucci D; Quinn JM; Degan M; Cozzi M; Perin V; Iuliis AD; Juzbasic S; Improta S; Athanasou NA; Ashman LK; Pinto A
Cell Growth Differ; 1996 Jun; 7(6):753-63. PubMed ID: 8780889
[TBL] [Abstract][Full Text] [Related]
15. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
16. Stem cell factor expression, mast cells and inflammation in asthma.
Da Silva CA; Reber L; Frossard N
Fundam Clin Pharmacol; 2006 Feb; 20(1):21-39. PubMed ID: 16448392
[TBL] [Abstract][Full Text] [Related]
17. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
Mekori YA; Oh CK; Metcalfe DD
J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
[TBL] [Abstract][Full Text] [Related]
18. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
Ali S; Ali S
Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
[TBL] [Abstract][Full Text] [Related]
19. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
[TBL] [Abstract][Full Text] [Related]
20. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
Beghini A; Cairoli R; Morra E; Larizza L
Blood Cells Mol Dis; 1998 Jun; 24(2):262-70. PubMed ID: 9714703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
